Portal de Periódicos da CAPES

How do I transfuse patients with sickle cell disease?

2010; Wiley; Volume: 50; Issue: 9 Linguagem: Inglês

10.1111/j.1537-2995.2010.02774.x

1537-2995

Keith Quirolo,

Erythrocyte Function and Pathophysiology

TransfusionVolume 50, Issue 9 p. 1881-1886 HOW DO I . . . ? How do I transfuse patients with sickle cell disease? Keith Quirolo, Keith QuiroloSearch for more papers by this author Keith Quirolo, Keith QuiroloSearch for more papers by this author First published: 01 September 2010 https://doi.org/10.1111/j.1537-2995.2010.02774.xCitations: 11 Keith Quirolo, MD, Department of Hematology, Pediatric Sickle Cell Program and Apheresis Program, Children's Hospital & Research Center Oakland, 747 52nd Street, Oakland, CA 94609; e-mail: [email protected]. From the Department of Hematology, Pediatric Sickle Cell Program and Apheresis Program, Children's Hospital & Research Center Oakland, Oakland, California. Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat REFERENCES 1 Strauss RG. Sickle cell patients deserve controlled recommendations. Transfusion 2002; 42: 658-9, author reply 9-60. 10.1046/j.1537-2995.2002.00140.x PubMedWeb of Science®Google Scholar 2 Lenfant C. The management of sickle cell disease. In: Lenfant C, editor. National Institutes of Health NH, Lung and Blood Institute, Division of Blood Diseases and Resources. Bethesda (MD): U.S. Department of Health and Human Services; 2002. p. 188. Google Scholar 3 Afenyi-Annan A, Willis MS, Konrad TR, Lottenberg R. Blood bank management of sickle cell patients at comprehensive sickle cell centers. Transfusion 2007; 47: 2089-97. 10.1111/j.1537-2995.2007.01434.x CASPubMedWeb of Science®Google Scholar 4 Vichinsky EP, Earles A, Johnson RA, Hoag MS, Williams A, Lubin B. Alloimmunization in sickle cell anemia and transfusion of racially unmatched blood. N Engl J Med 1990; 322: 1617-21. 10.1056/NEJM199006073222301 CASPubMedWeb of Science®Google Scholar 5 Ribeiro KR, Guarnieri MH, Da Costa DC, Costa FF, Pellegrino J Jr, Castilho L. DNA array analysis for red blood cell antigens facilitates the transfusion support with antigen-matched blood in patients with sickle cell disease. Vox Sang 2009; 97: 147-52. 10.1111/j.1423-0410.2009.01185.x CASPubMedWeb of Science®Google Scholar 6 Aygun B, Padmanabhan S, Paley C, Chandrasekaran V. Clinical significance of RBC alloantibodies and autoantibodies in sickle cell patients who received transfusions. Transfusion 2002; 42: 37-43. 10.1046/j.1537-2995.2002.00007.x CASPubMedWeb of Science®Google Scholar 7 Vichinsky EP, Luban NL, Wright E, Olivieri N, Driscoll C, Pegelow CH, Adams RJ. Prospective RBC phenotype matching in a stroke-prevention trial in sickle cell anemia: a multicenter transfusion trial. Transfusion 2001; 41: 1086-92. 10.1046/j.1537-2995.2001.41091086.x CASPubMedWeb of Science®Google Scholar 8 Bao W, Yu J, Heck S, Yazdanbakhsh K. Regulatory T-cell status in red cell alloimmunized responder and nonresponder mice. Blood 2009; 113: 5624-7. 10.1182/blood-2008-12-193748 CASPubMedWeb of Science®Google Scholar 9 Alexy T, Pais E, Armstrong JK, Meiselman HJ, Johnson CS, Fisher TC. Rheologic behavior of sickle and normal red blood cell mixtures in sickle plasma: implications for transfusion therapy. Transfusion 2006; 46: 912-8. 10.1111/j.1537-2995.2006.00823.x CASPubMedWeb of Science®Google Scholar 10 Swerdlow PS. Red cell exchange in sickle cell disease. Hematology Am Soc Hematol Educ Program 2006; 48-53. 10.1182/asheducation-2006.1.48 PubMedGoogle Scholar 11 Turner JM, Kaplan JB, Cohen HW, Billett HH. Exchange versus simple transfusion for acute chest syndrome in sickle cell anemia adults. Transfusion 2009. 10.1111/j.1537-2995.2008.02075.x PubMedWeb of Science®Google Scholar 12 Hulbert ML, Scothorn DJ, Panepinto JA, Scott JP, Buchanan GR, Sarnaik S, Fallon R, Chu JY, Wang W, Casella JF, Resar L, Berman B, Adamkiewicz T, Hsu LL, Smith-Whitley K, Mahoney D, Woods G, Watanabe M, DeBaun MR. Exchange blood transfusion compared with simple transfusion for first overt stroke is associated with a lower risk of subsequent stroke: a retrospective cohort study of 137 children with sickle cell anemia. J Pediatr 2006; 149: 710-2. 10.1016/j.jpeds.2006.06.037 PubMedWeb of Science®Google Scholar 13 Singer ST, Quirolo K, Nishi K, Hackney-Stephens E, Evans C, Vichinsky EP. Erythrocytapheresis for chronically transfused children with sickle cell disease: an effective method for maintaining a low hemoglobin S level and reducing iron overload. J Clin Apher 1999; 14: 122-5. 10.1002/(SICI)1098-1101(1999)14:3 3.0.CO;2-A CASPubMedWeb of Science®Google Scholar 14 Szczepiorkowski ZM, Bandarenko N, Kim HC, Linenberger ML, Marques MB, Sarode R, Schwartz J, Shaz BH, Weinstein R, Wirk A, Winters JL. Guidelines on the use of therapeutic apheresis in clinical practice: evidence-based approach from the Apheresis Applications Committee of the American Society for Apheresis. J Clin Apher 2007; 22: 106-75. 10.1002/jca.20129 PubMedWeb of Science®Google Scholar 15 Kim HC, Dugan NP, Silber JH, Martin MB, Schwartz E, Ohene-Frempong K, Cohen AR. Erythrocytapheresis therapy to reduce iron overload in chronically transfused patients with sickle cell disease. Blood 1994; 83: 1136-42. 10.1182/blood.V83.4.1136.1136 CASPubMedWeb of Science®Google Scholar 16 Adams DM, Schultz WH, Ware RE, Kinney TR. Erythrocytapheresis can reduce iron overload and prevent the need for chelation therapy in chronically transfused pediatric patients. J Pediatr Hematol Oncol 1996; 18: 46-50. 10.1097/00043426-199602000-00009 CASPubMedWeb of Science®Google Scholar 17 Jeng MR, Feusner J, Skibola C, Vichinsky E. Central venous catheter complications in sickle cell disease. Am J Hematol 2002; 69: 103-8. 10.1002/ajh.10047 PubMedWeb of Science®Google Scholar 18 Castro O, Poillon WN, Finke H, Massac E. Improvement of sickle cell anemia by iron-limited erythropoiesis. Am J Hematol 1994; 47: 74-81. 10.1002/ajh.2830470203 CASPubMedWeb of Science®Google Scholar 19 Vichinsky EP, Haberkern CM, Neumayr L, Earles AN, Black D, Koshy M, Pegelow C, Abboud M, Ohene-Frempong K, Iyer RV. A comparison of conservative and aggressive transfusion regimens in the perioperative management of sickle cell disease. The Preoperative Transfusion in Sickle Cell Disease Study Group. N Engl J Med 1995; 333: 206-13. 10.1056/NEJM199507273330402 CASPubMedWeb of Science®Google Scholar 20 Koshy M, Weiner SJ, Miller ST, Sleeper LA, Vichinsky E, Brown AK, Khakoo Y, Kinney TR. Surgery and anesthesia in sickle cell disease. Cooperative Study of Sickle Cell Diseases. Blood 1995; 86: 3676-84. 10.1182/blood.V86.10.3676.bloodjournal86103676 CASPubMedWeb of Science®Google Scholar 21 Adams RJ, McKie VC, Hsu L, Files B, Vichinsky E, Pegelow C, Abboud M, Gallagher D, Kutlar A, Nichols FT, Bonds DR, Brambilla D. Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonography. N Engl J Med 1998; 339: 5-11. 10.1056/NEJM199807023390102 CASPubMedWeb of Science®Google Scholar 22 Adams RJ. Big strokes in small persons. Arch Neurol 2007; 64: 1567-74. 10.1001/archneur.64.11.1567 PubMedWeb of Science®Google Scholar 23 Lefevre N, Dufour D, Gulbis B, Le PQ, Heijmans C, Ferster A. Use of hydroxyurea in prevention of stroke in children with sickle cell disease. Blood 2008; 111: 963-4, author reply 4. 10.1182/blood-2007-08-102244 CASPubMedWeb of Science®Google Scholar 24 Ware RE, Zimmerman SA, Sylvestre PB, Mortier NA, Davis JS, Treem WR, Schultz WH. Prevention of secondary stroke and resolution of transfusional iron overload in children with sickle cell anemia using hydroxyurea and phlebotomy. J Pediatr 2004; 145: 346-52. 10.1016/j.jpeds.2004.04.058 CASPubMedWeb of Science®Google Scholar 25 Wang WC, Kovnar EH, Tonkin IL, Mulhern RK, Langston JW, Day SW, Schell MJ, Wilimas JA. High risk of recurrent stroke after discontinuance of five to twelve years of transfusion therapy in patients with sickle cell disease. J Pediatr 1991; 118: 377-82. 10.1016/S0022-3476(05)82150-X PubMedWeb of Science®Google Scholar 26 Verduzco LA, Nathan DG. Sickle cell disease and stroke. Blood 2009; 114: 5117-25. 10.1182/blood-2009-05-220921 CASPubMedWeb of Science®Google Scholar 27 Dobson SR, Holden KR, Nietert PJ, Cure JK, Laver JH, Disco D, Abboud MR. Moyamoya syndrome in childhood sickle cell disease: a predictive factor for recurrent cerebrovascular events. Blood 2002; 99: 3144-50. 10.1182/blood.V99.9.3144 CASPubMedWeb of Science®Google Scholar 28 Fryer RH, Anderson RC, Chiriboga CA, Feldstein NA. Sickle cell anemia with moyamoya disease: outcomes after EDAS procedure. Pediatr Neurol 2003; 29: 124-30. 10.1016/S0887-8994(03)00047-X PubMedWeb of Science®Google Scholar 29 Vendt BA, McKinstry RC, Ball WS, Kraut MA, Prior FW, Barton B, Casella JF, DeBaun MR. Silent Cerebral Infarct Transfusion (SIT) trial imaging core: application of novel imaging information technology for rapid and central review of MRI of the brain. J Digit Imaging 2009; 22: 326-43. 10.1007/s10278-008-9114-3 PubMedWeb of Science®Google Scholar 30 Vichinsky EP, Neumayr LD, Earles AN, Williams R, Lennette ET, Dean D, Nickerson B, Orringer E, McKie V, Bellevue R, Daeschner C, Manci EA. Causes and outcomes of the acute chest syndrome in sickle cell disease. National Acute Chest Syndrome Study Group. N Engl J Med 2000; 342: 1855-65. 10.1056/NEJM200006223422502 CASPubMedWeb of Science®Google Scholar 31 Vichinsky EP, Styles LA, Colangelo LH, Wright EC, Castro O, Nickerson B. Acute chest syndrome in sickle cell disease: clinical presentation and course. Cooperative Study of Sickle Cell Disease. Blood 1997; 89: 1787-92. 10.1182/blood.V89.5.1787 CASPubMedWeb of Science®Google Scholar 32 Ohene-Frempong K, Weiner SJ, Sleeper LA, Miller ST, Embury S, Moohr JW, Wethers DL, Pegelow CH, Gill FM. Cerebrovascular accidents in sickle cell disease: rates and risk factors. Blood 1998; 91: 288-94. CASPubMedWeb of Science®Google Scholar 33 Hankins J, Jeng M, Harris S, Li CS, Liu T, Wang W. Chronic transfusion therapy for children with sickle cell disease and recurrent acute chest syndrome. J Pediatr Hematol Oncol 2005; 27: 158-61. 10.1097/01.mph.0000157789.73706.53 PubMedWeb of Science®Google Scholar 34 Fitzhugh CD, Lauder N, Jonassaint JC, Telen MJ, Zhao X, Wright EC, Gilliam FR, De Castro LM. Cardiopulmonary complications leading to premature deaths in adult patients with sickle cell disease. Am J Hematol 2010; 85: 36-40. 10.1002/ajh.21569 PubMedWeb of Science®Google Scholar 35 Singh SA, Koumbourlis AC, Aygun B. Resolution of chronic hypoxemia in pediatric sickle cell patients after treatment with hydroxyurea. Pediatr Blood Cancer 2008; 50: 1258-60. 10.1002/pbc.21480 PubMedWeb of Science®Google Scholar 36 Villers MS, Jamison MG, De Castro LM, James AH. Morbidity associated with sickle cell disease in pregnancy. Am J Obstet Gynecol 2008; 199: 125.e1-5. 10.1016/j.ajog.2008.04.016 PubMedWeb of Science®Google Scholar 37 Koshy M, Burd L, Wallace D, Moawad A, Baron J. Prophylactic red-cell transfusions in pregnant patients with sickle cell disease. A randomized cooperative study. N Engl J Med 1988; 319: 1447-52. 10.1056/NEJM198812013192204 CASPubMedWeb of Science®Google Scholar 38 Morrison JC, Morrison FS, Floyd RC, Roberts WE, Hess LW, Wiser WL. Use of continuous flow erythrocytapheresis in pregnant patients with sickle cell disease. J Clin Apher 1991; 6: 224-9. 10.1002/jca.2920060411 CASPubMedWeb of Science®Google Scholar 39 Gladwin MT, Sachdev V, Jison ML, Shizukuda Y, Plehn JF, Minter K, Brown B, Coles WA, Nichols JS, Ernst I, Hunter LA, Blackwelder WC, Schechter AN, Rodgers GP, Castro O, Ognibene FP. Pulmonary hypertension as a risk factor for death in patients with sickle cell disease. N Engl J Med 2004; 350: 886-95. 10.1056/NEJMoa035477 CASPubMedWeb of Science®Google Scholar 40 Lee MT, Small T, Khan MA, Rosenzweig EB, Barst RJ, Brittenham GM. Doppler-defined pulmonary hypertension and the risk of death in children with sickle cell disease followed for a mean of three years. Br J Haematol 2009; 146: 437-41. 10.1111/j.1365-2141.2009.07779.x PubMedWeb of Science®Google Scholar 41 Vichinsky E, Neumayr L, Gold J, Weiner M, Rule R. Neuropsychological dysfunction and neuroimaging abnormalities in neurologically intact adults with sickle cell anemia. JAMA 2010; 303: 1823-31. 10.1001/jama.2010.562 PubMedWeb of Science®Google Scholar 42 Talano JA, Hillery CA, Gottschall JL, Baylerian DM, Scott JP. Delayed hemolytic transfusion reaction/hyperhemolysis syndrome in children with sickle cell disease. Pediatrics 2003; 111: e661-5. 10.1542/peds.111.6.e661 PubMedWeb of Science®Google Scholar 43 Ballas SK, Marcolina MJ. Hyperhemolysis during the evolution of uncomplicated acute painful episodes in patients with sickle cell anemia. Transfusion 2006; 46: 105-10. 10.1111/j.1537-2995.2006.00679.x PubMedWeb of Science®Google Scholar 44 Win N, New H, Lee E, De La Fuente J. Hyperhemolysis syndrome in sickle cell disease: case report (recurrent episode) and literature review. Transfusion 2008; 48: 1231-8. 10.1111/j.1537-2995.2008.01693.x CASPubMedWeb of Science®Google Scholar Citing Literature Volume50, Issue9September 2010Pages 1881-1886 ReferencesRelatedInformation